Home / Publications / RuII and RuIII complexes with 2,6-di-tert-butylphenol ligands: synthesis, electrochemical behaviour, antioxidant properties and antiproliferative activity

RuII and RuIII complexes with 2,6-di-tert-butylphenol ligands: synthesis, electrochemical behaviour, antioxidant properties and antiproliferative activity

Anastasia Aleksandrovna Antonets 1
Anastasia Aleksandrovna Antonets
, 
Ksenia Mikhailovna Voroshilkina 1
Ksenia Mikhailovna Voroshilkina
,  ,  ,  , 
Ludmila Gennad'evna Dubova 2
Ludmila Gennad'evna Dubova
, 
Elena Feofanovna Shevtsova 2
Elena Feofanovna Shevtsova
,  , 
1 Department of Chemistry, M.V. Lomonosov Moscow State University, Moscow, Russian Federation
2 Institute of Physiologically Active Compounds, Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russian Federation
10.1016/j.mencom.2024.01.022
Published 2023-12-25
Communication , Volume 34, Issue 1, 74-77
1
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Antonets A. A. et al. RuII and RuIII complexes with 2,6-di-tert-butylphenol ligands: synthesis, electrochemical behaviour, antioxidant properties and antiproliferative activity // Mendeleev Communications. 2023. Vol. 34. No. 1. pp. 74-77.
GOST all authors (up to 50) Copy
Antonets A. A., Voroshilkina K. M., Shutkov I. A., Mazur D. M., Tyurin V. Y., Dubova L. G., Shevtsova E. F., Nazarov A. A., Milaeva E. R. RuII and RuIII complexes with 2,6-di-tert-butylphenol ligands: synthesis, electrochemical behaviour, antioxidant properties and antiproliferative activity // Mendeleev Communications. 2023. Vol. 34. No. 1. pp. 74-77.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2024.01.022
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2024.01.022
TI - RuII and RuIII complexes with 2,6-di-tert-butylphenol ligands: synthesis, electrochemical behaviour, antioxidant properties and antiproliferative activity
T2 - Mendeleev Communications
AU - Antonets, Anastasia Aleksandrovna
AU - Voroshilkina, Ksenia Mikhailovna
AU - Shutkov, Ilya Aleksandrovich
AU - Mazur, Dmitrii Mikhailovich
AU - Tyurin, Vladimir Yuryevich
AU - Dubova, Ludmila Gennad'evna
AU - Shevtsova, Elena Feofanovna
AU - Nazarov, Alexey Anatol'evich
AU - Milaeva, Elena Rudol'fovna
PY - 2023
DA - 2023/12/25
PB - Mendeleev Communications
SP - 74-77
IS - 1
VL - 34
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Antonets,
author = {Anastasia Aleksandrovna Antonets and Ksenia Mikhailovna Voroshilkina and Ilya Aleksandrovich Shutkov and Dmitrii Mikhailovich Mazur and Vladimir Yuryevich Tyurin and Ludmila Gennad'evna Dubova and Elena Feofanovna Shevtsova and Alexey Anatol'evich Nazarov and Elena Rudol'fovna Milaeva},
title = {RuII and RuIII complexes with 2,6-di-tert-butylphenol ligands: synthesis, electrochemical behaviour, antioxidant properties and antiproliferative activity},
journal = {Mendeleev Communications},
year = {2023},
volume = {34},
publisher = {Mendeleev Communications},
month = {Dec},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2024.01.022},
number = {1},
pages = {74--77},
doi = {10.1016/j.mencom.2024.01.022}
}
MLA
Cite this
MLA Copy
Antonets, Anastasia Aleksandrovna, et al. “RuII and RuIII complexes with 2,6-di-tert-butylphenol ligands: synthesis, electrochemical behaviour, antioxidant properties and antiproliferative activity.” Mendeleev Communications, vol. 34, no. 1, Dec. 2023, pp. 74-77. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2024.01.022.
Views / Downloads
1 / 5

Keywords

antioxidant activity
antiproliferative activity
CUPRAC assay
DPPH assay
electrochemical behaviour
lipid peroxidation.
ruthenium compounds

Abstract

New ruthenium(ii) and ruthenium(iii) complexes with 2,6-di-tert-butylphenol as the antioxidant moiety were synthesized, and their antioxidant and antiproliferative activities were evaluated. Electrochemical behaviour and the potential of these compounds to act as inhibitors of lipid peroxidation in biological systems were explored.

References

.
Fateeva A.A., Shutkov I.A., Mazur D.M., Kovaleva O.N., Milaeva E.R., Nazarov A.A.
Mendeleev Communications, 2022
.
Cytotoxic activity of organotin compounds containing non-steroidal anti-inflammatory drugs
Antonenko T.A., Gracheva Y.A., Shpakovsky D.B., Vorobyev M.A., Tafeenko V.A., Mazur D.M., Milaeva E.R.
Journal of Organometallic Chemistry, 2022
.
Novel selective anticancer agents based on Sn and Au complexes. Mini-review
Milaeva E.R., Shpakovsky D.B., Gracheva Y.A., Antonenko T.A., Ksenofontova T.D., Nikitin E.A., Berseneva D.A.
Pure and Applied Chemistry, 2020
.
Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
Petruzzella E., Sirota R., Solazzo I., Gandin V., Gibson D.
Chemical Science, 2018
.
Ru(III) Complexes with Lonidamine-Modified Ligands
Shutkov I.A., Okulova Y.N., Tyurin V.Y., Sokolova E.V., Babkov D.A., Spasov A.A., Gracheva Y.A., Schmidt C., Kirsanov K.I., Shtil A.A., Redkozubova O.M., Shevtsova E.F., Milaeva E.R., Ott I., Nazarov A.A., et. al.
International Journal of Molecular Sciences, 2021
.
Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates?
Coverdale J., Laroiya-McCarron T., Romero-Canelón I.
Inorganics, 2019
.
Metallodrug Profiling against SARS-CoV-2 Target Proteins Identifies Highly Potent Inhibitors of the Spike/ACE2 interaction and the Papain-like Protease PLpro.
Gil‐Moles M., Türck S., Basu U., Pettenuzzo A., Bhattacharya S., Rajan A., Ma X., Büssing R., Wölker J., Burmeister H., Hoffmeister H., Schneeberg P., Prause A., Lippmann P., Kusi‐Nimarko J., et. al.
Chemistry - A European Journal, 2021
.
Enhancing the cytotoxic activity of anticancer Pt(IV) complexes by introduction of lonidamine as an axial ligand
Nosova Y.N., Foteeva L.S., Zenin I.V., Fetisov T.I., Kirsanov K.I., Yakubovskaya M.G., Antonenko T.A., Tafeenko V.A., Aslanov L.A., Lobas A.A., Gorshkov M.V., Galanski M., Keppler B.K., Timerbaev A.R., Milaeva E.R., et. al.
European Journal of Inorganic Chemistry, 2016
.
Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents
Shutkov I.A., Antonets A.A., Tyurin V.Y., Milaeva E.R., Nazarov A.A.
Russian Journal of Inorganic Chemistry, 2021
.
Electron-transfer activated metal-based anticancer drugs
Reisner E., Arion V.B., Keppler B.K., Pombeiro A.J.
Inorganica Chimica Acta, 2008
.
The development of RAPTA compounds for the treatment of tumors
Murray B.S., Babak M.V., Hartinger C.G., Dyson P.J.
Coordination Chemistry Reviews, 2016
.
New highly cytotoxic organic and organometallic bexarotene derivatives
Nosova Y.N., Karlov D.S., Pisarev S.A., Shutkov I.A., Palyulin V.A., Baquié M., Milaeva E.R., Dyson P.J., Nazarov A.A.
Journal of Organometallic Chemistry, 2017
.
Synthesis, structural characterization and in vitro inhibitory studies against human breast cancer of the bis-(2,6-di-tert-butylphenol)tin(IV) dichloride and its complexes.
Shpakovsky D.B., Banti C.N., Beaulieu-Houle G., Kourkoumelis N., Manoli M., Manos M.J., Tasiopoulos A.J., Hadjikakou S.K., Milaeva E.R., Charalabopoulos K., Bakas T., Butler I.S., Hadjiliadis N.
Dalton Transactions, 2012
.
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Leijen S., Burgers S.A., Baas P., Pluim D., Tibben M., van Werkhoven E., Alessio E., Sava G., Beijnen J.H., Schellens J.H.
Investigational New Drugs, 2014
.
Structural Motifs and Biological Studies of New Antimony(III) Iodide Complexes with Thiones
Ozturk I., Filimonova S., Hadjikakou S.K., Kourkoumelis N., Dokorou V., Manos M.J., Tasiopoulos A.J., Barsan M.M., Butler I.S., Milaeva E.R., Balzarini J., Hadjiliadis N.
Inorganic Chemistry, 2009
.
Hydrolytically stable organometallic ruthenium complexes with glucose-based phosphite ligands
Gonchar M.R., Ninin F.S., Milaeva E.R., Nazarov A.A.
Russian Chemical Bulletin, 2022
.
Metal-based antitumor compounds: beyond cisplatin.
Simpson P.V., Desai N.M., Casari I., Massi M., Falasca M.
Future Medicinal Chemistry, 2019
.
Novel organotin complexes with phenol and imidazole moieties for optimized antitumor properties
Nikitin E.A., Shpakovsky D.B., Tyurin V.Y., Kazak A.A., Gracheva Y.A., Vasilichin V.A., Pavlyukov M.S., Mironova E.M., Gontcharenko V.E., Lyssenko K.A., Antonets A.A., Dubova L.G., Shevtsov P.N., Shevtsova E.F., Shamraeva M.A., et. al.
Journal of Organometallic Chemistry, 2022
.
New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents
Shutkov I.A., Okulova Y.N., Mazur D.M., Melnichuk N.A., Babkov D.A., Sokolova E.V., Spasov A.A., Milaeva E.R., Nazarov A.A.
Pharmaceutics, 2023